Geode Capital Management, LLC Aclaris Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,565,054 shares of ACRS stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,565,054
Previous 1,393,548
12.31%
Holding current value
$1.72 Million
Previous $1.46 Million
32.6%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ACRS
# of Institutions
102Shares Held
53.5MCall Options Held
51KPut Options Held
31.6K-
Bml Capital Management, LLC Zionsville, IN9.4MShares$10.3 Million7.8% of portfolio
-
Black Rock Inc. New York, NY5.2MShares$5.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$5.42 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.28MShares$3.61 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$3.6 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $73.3M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...